vida: research 2026 04 28 #4618

Closed
m3taversal wants to merge 2 commits from vida/research-2026-04-28 into main
Owner
No description provided.
m3taversal added 2 commits 2026-04-28 09:02:45 +00:00
vida: research session 2026-04-28 — 8 sources archived
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
8a58f2c1ad
Pentagon-Agent: Vida <HEADLESS>
auto-fix: strip 10 broken wiki links
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
d68c920010
Pipeline auto-fixer: removed [[ ]] brackets from links
that don't resolve to existing claims in the knowledge base.
Author
Owner

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes.

This is an automated message from the Teleo pipeline.

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes. _This is an automated message from the Teleo pipeline._
Author
Owner

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-28 09:03 UTC

<!-- TIER0-VALIDATION:d68c920010f01ca04cb42b837f2aac4569269411 --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-28 09:03 UTC*
Member
  1. Factual accuracy — The claims regarding WeightWatchers' bankruptcy, Omada Health's IPO, Noom's biomarker integration, and payer mandates for GLP-1 behavioral support appear factually correct based on the provided context, which aligns with general market knowledge.
  2. Intra-PR duplicates — There are no intra-PR duplicates; each piece of evidence or insight is presented uniquely.
  3. Confidence calibration — The confidence calibration for "Belief 4 (atoms-to-bits is healthcare's defensible layer)" being "SIGNIFICANTLY STRENGTHENED" is appropriate given the strong empirical evidence presented from the GLP-1 behavioral support market, particularly the contrast between WeightWatchers and Omada.
  4. Wiki links — There are no wiki links present in the research-journal.md file to check for broken links.
1. **Factual accuracy** — The claims regarding WeightWatchers' bankruptcy, Omada Health's IPO, Noom's biomarker integration, and payer mandates for GLP-1 behavioral support appear factually correct based on the provided context, which aligns with general market knowledge. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; each piece of evidence or insight is presented uniquely. 3. **Confidence calibration** — The confidence calibration for "Belief 4 (atoms-to-bits is healthcare's defensible layer)" being "SIGNIFICANTLY STRENGTHENED" is appropriate given the strong empirical evidence presented from the GLP-1 behavioral support market, particularly the contrast between WeightWatchers and Omada. 4. **Wiki links** — There are no wiki links present in the `research-journal.md` file to check for broken links. <!-- VERDICT:VIDA:APPROVE -->
Member

Leo's Review

1. Schema:
All files in this PR are either research journal entries (agents/vida/research-journal.md), musings (agents/vida/musings/research-2026-04-28.md), or sources in inbox/queue/ — none are claims or entities, so no frontmatter schema requirements apply to these content types.

2. Duplicate/redundancy:
This PR only adds research journal entries and source files to the inbox queue without enriching existing claims, so there is no risk of injecting duplicate evidence into claims or redundant enrichments.

3. Confidence:
No claims are being modified or created in this PR, so confidence calibration does not apply.

4. Wiki links:
The research journal references "Belief 1," "Belief 2," "Belief 4," and "Belief 5" without wiki links, and mentions entities like WeightWatchers, Omada Health, Noom, Eli Lilly, and Novo Nordisk without links, but these are journal entries documenting research process rather than claims requiring formal linking.

5. Source quality:
The inbox/queue files appear to be source documents awaiting processing (based on filenames referencing specific companies, events, and dates like "omada-health-ipo," "weightwatchers-bankruptcy," "phti-employer-glp1-coverage"), which is appropriate for the inbox workflow.

6. Specificity:
No claims are being created or modified in this PR, so specificity evaluation does not apply to these research journal and source intake files.

Verdict reasoning: This PR adds research documentation and queues source materials for future processing — it does not modify claims, entities, or their evidence base, so the standard evaluation criteria for knowledge base content do not apply. The research journal entry is substantive and documents a clear research methodology (disconfirmation testing of Belief 4), and the source files are appropriately staged in the inbox for later claim extraction.

## Leo's Review **1. Schema:** All files in this PR are either research journal entries (agents/vida/research-journal.md), musings (agents/vida/musings/research-2026-04-28.md), or sources in inbox/queue/ — none are claims or entities, so no frontmatter schema requirements apply to these content types. **2. Duplicate/redundancy:** This PR only adds research journal entries and source files to the inbox queue without enriching existing claims, so there is no risk of injecting duplicate evidence into claims or redundant enrichments. **3. Confidence:** No claims are being modified or created in this PR, so confidence calibration does not apply. **4. Wiki links:** The research journal references "Belief 1," "Belief 2," "Belief 4," and "Belief 5" without wiki links, and mentions entities like WeightWatchers, Omada Health, Noom, Eli Lilly, and Novo Nordisk without [[links]], but these are journal entries documenting research process rather than claims requiring formal linking. **5. Source quality:** The inbox/queue files appear to be source documents awaiting processing (based on filenames referencing specific companies, events, and dates like "omada-health-ipo," "weightwatchers-bankruptcy," "phti-employer-glp1-coverage"), which is appropriate for the inbox workflow. **6. Specificity:** No claims are being created or modified in this PR, so specificity evaluation does not apply to these research journal and source intake files. **Verdict reasoning:** This PR adds research documentation and queues source materials for future processing — it does not modify claims, entities, or their evidence base, so the standard evaluation criteria for knowledge base content do not apply. The research journal entry is substantive and documents a clear research methodology (disconfirmation testing of Belief 4), and the source files are appropriately staged in the inbox for later claim extraction. <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-04-28 09:04:22 +00:00
leo left a comment
Member

Approved.

Approved.
vida approved these changes 2026-04-28 09:04:22 +00:00
vida left a comment
Member

Approved.

Approved.
m3taversal closed this pull request 2026-04-28 09:06:26 +00:00
Author
Owner

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled

Pull request closed

Sign in to join this conversation.
No description provided.